(Hypertension. 1996;27:794-798.)
© 1996 American Heart Association, Inc.
Articles |
Effects of Endothelin Receptor Inhibition on Cerebral Arterioles in Hypertensive Rats
From the University of Iowa College of Medicine, Departments of Pathology (J-M.C. and G.L.B.), Internal Medicine and Pharmacology (D.D.H.), and the Cardiovascular Center, Iowa City, Ia.
Abstract The purpose of this study was to examine the effects of endothelin receptor inhibition on cerebral arterioles in stroke-prone spontaneously hypertensive rats (SHRSP). Structure and mechanics of cerebral arterioles were examined in untreated Wistar-Kyoto rats (WKY) and SHRSP that were either untreated or treated for 3 months with bosentan, an inhibitor of endothelin receptors (100 mg/kg per day). We measured pressure, external diameter, and cross-sectional area of the vessel wall (histologically) in maximally dilated (EDTA) arterioles on the cerebrum. Bosentan reduced but did not normalize arteriolar mean pressure (103±3 and 81±5 mm Hg in untreated and treated SHRSP versus 51±4 mm Hg in WKY, P<.05; mean±SEM) and pulse pressure (40±2 and 33±2 mm Hg in untreated and treated SHRSP versus 25±3 mm Hg in WKY, P<.05) in SHRSP. Cross-sectional area of the vessel wall (CSA) was increased in untreated SHRSP (1627±173 µm2), and CSA in treated SHRSP (1287±78 µm2) was similar to that in WKY (1299±65 µm2). Bosentan had no effect on reductions in external diameter (remodeling) of cerebral arterioles (104±7 and 96±4 µm in untreated and treated SHRSP compared with 126±7 µm in WKY, P<.05). Stress-strain curves indicate that bosentan had no significant effect on distensibility of arterioles on the cerebrum in SHRSP. The results suggest that endothelin-1 may contribute to the development of hypertrophy, but not remodeling or changes in distensibility, of cerebral arterioles in SHRSP.
Key Words: arterioles • endothelin • hypertrophy • bosentan • rats
This article has been cited by other articles:
 |
|
 |
|
  G. L. Baumbach, C. D. Sigmund, and F. M. Faraci Structure of Cerebral Arterioles in Mice Deficient in Expression of the Gene for Endothelial Nitric Oxide Synthase Circ. Res., October 15, 2004; 95(8): 822 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-M. Chillon and G. L. Baumbach Effects of Indapamide, a Thiazide-Like Diuretic, on Structure of Cerebral Arterioles in Hypertensive Rats Hypertension, May 1, 2004; 43(5): 1092 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Baumbach, C. D. Sigmund, and F. M. Faraci Cerebral Arteriolar Structure in Mice Overexpressing Human Renin and Angiotensinogen Hypertension, January 1, 2003; 41(1): 50 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Quehenberger, M. Exner, R. Sunder-Plassmann, K. Ruzicka, C. Bieglmayer, G. Endler, C. Muellner, W. Speiser, and O. Wagner Leptin Induces Endothelin-1 in Endothelial Cells In Vitro Circ. Res., April 5, 2002; 90(6): 711 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V Agapitov and W. G Haynes Role of endothelin in cardiovascular disease Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1): 1 - 15. [Abstract] [PDF]
|
|
|
|
|
|
D. Z. Ye and D. H. Wang Function and Regulation of Endothelin-1 and Its Receptors in Salt Sensitive Hypertension Induced by Sensory Nerve Degeneration Hypertension, February 1, 2002; 39(2): 673 - 678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Regrigny, F. Dupuis, J. Atkinson, P. Liminana, E. Scalbert, P. Delagrange, and J.-M. Chillon Cerebral arteriolar structure and function in pinealectomized rats Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1476 - H1480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. Intengan and E. L. Schiffrin Vasopeptidase Inhibition Has Potent Effects on Blood Pressure and Resistance Arteries in Stroke-Prone Spontaneously Hypertensive Rats Hypertension, June 1, 2000; 35(6): 1221 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Regrigny, J. Atkinson, C. Capdeville-Atkinson, P. Liminana, and J.-M. Chillon Effect of Lovastatin on Cerebral Circulation in Spontaneously Hypertensive Rats Hypertension, May 1, 2000; 35(5): 1105 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Schiffrin Role of Endothelin-1 in Hypertension Hypertension, October 1, 1999; 34(4): 876 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Chillon and G. L. Baumbach Effects of an Angiotensin-Converting Enzyme Inhibitor and a ß-Blocker on Cerebral Arterioles in Rats Hypertension, March 1, 1999; 33(3): 856 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Moreau Endothelin in hypertension: A role for receptor antagonists? Cardiovasc Res, September 1, 1998; 39(3): 534 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J Rabelink, E. S.G Stroes, K.P. Bouter, and P. Morrison Endothelin blockers and renal protection: a new strategy to prevent end-organ damage in cardiovascular disease? Cardiovasc Res, September 1, 1998; 39(3): 543 - 549. [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Chillon, S. Ghoneim, and G. L. Baumbach Effects of Chronic Nitric Oxide Synthase Inhibition on Cerebral Arterioles in Rats Hypertension, November 1, 1997; 30(5): 1097 - 1104. [Abstract] [Full Text]
|
|
|
|
|
|
L. V. d'Uscio, M. Barton, S. Shaw, P. Moreau, and T. F. Luscher Structure and Function of Small Arteries in Salt-Induced Hypertension : Effects of Chronic Endothelin-Subtype-A–Receptor Blockade Hypertension, October 1, 1997; 30(4): 905 - 911. [Abstract] [Full Text]
|
|
|
|
|
|
P. Quehenberger, M. Exner, R. Sunder-Plassmann, K. Ruzicka, C. Bieglmayer, G. Endler, C. Muellner, W. Speiser, and O. Wagner Leptin Induces Endothelin-1 in Endothelial Cells In Vitro Circ. Res., April 5, 2002; 90(6): 711 - 718. [Abstract] [Full Text] [PDF]
|
|